Assessing Population Diversity in Phase III Trials of Cancer Drugs Supporting FDA Approval in Solid Tumors-Reference-Cited by-同舟云学术

Assessing Population Diversity in Phase III Trials of Cancer Drugs Supporting FDA Approval in Solid Tumors

Published:2021-06-14 Issue: Volume: Page:
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Yekedüz Emre¹^ORCID,Trapani Dario²^ORCID,Xu Wenxin³,Vries Elisabeth GE⁴,Labaki Chris³,Gyawali Bishal⁵,Gulati Shuchi⁶,Nabhan Chadi⁷,Utkan Güngör¹,Curigliano Giuseppe²⁸,Choueiri Toni K.³,Ürün Yüksel¹

Affiliation:

1. Department of Medical Oncology Ankara University School of Medicine Ankara Turkey

2. European Institute of Oncology, IRCCS Milan Italy

3. Dana‐Farber Cancer Institute Boston USA

4. University Medical Center Groningen University of Groningen Groningen The Netherlands

5. Queen's University School of Medicine Cancer Research Institute Kingston Canada

6. Division of Hematology and Oncology University of Cincinnati Cincinnati OH USA

7. Caris Life Sciences Irving TX USA

8. Department of Oncology and Hematology (DIPO) University of Milan Milan Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33708

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022;Annals of Oncology;2024-07

2. Strategies for increasing accrual in cancer clinical trials: What is the evidence?;Cancer Medicine;2024-05

3. A systematic review of ethnic minority participation in randomised controlled trials of systemic therapies for gynecological cancers;Gynecologic Oncology;2024-05

4. Demographic Diversity of Clinical Trials for Therapeutic Drug Products: A Systematic Review of Recently Published Articles, 2017‐2022;The Journal of Clinical Pharmacology;2024-01-20

5. Equitable Access to Clinical Trials: How Do We Achieve It?;American Society of Clinical Oncology Educational Book;2023-05